Document Detail


Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status.
MedLine Citation:
PMID:  17130844     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The contribution of different proteolytic systems, in particular calpains and effector caspases, in apoptotic cell death is still controversial. In this paper, we show that during cisplatin-induced apoptosis of human metastatic melanoma cells, calpain activation, as measured in intact cells by two different fluorescent substrates, is an early event, taking place well before caspase-3/-7 activation, and progressively increasing during 48 h of treatment. Such activation appears to be independent from any intracellular calcium imbalance; in fact, an increase of cytosolic calcium along with emptying of the reticular stores occur only at very late stages, uniquely in frankly apoptotic, detached cells. Calpain activation proves to be an early and crucial event in the apoptotic machinery, as demonstrated by the significant protection of cell death in samples co-treated with the calpain inhibitors, MDL 28170, calpeptin and PD 150606, where a variable but significant reduction of both caspase-3/-7 activity and cell detachment is observed. Consistently, such a protective effect can be at least partially due to the impairment of cisplatin-induced p53 activation, occurring early in committed, preapoptotic cells. Furthermore, in late apoptotic cells, calpain activity is also responsible for the formation of a novel p53 proteolytic fragment (approximately 26 kDa), whose function is so far to be elucidated.
Authors:
B Del Bello; D Moretti; A Gamberucci; E Maellaro
Related Documents :
10713134 - Inhibition of homodimerization of poly(adp-ribose) polymerase by its c-terminal cleavag...
12115584 - Involvement of human heat shock protein 90 alpha in nicotine-induced apoptosis.
19913524 - Apoptosis induction in human leukemic cells by a novel protein bengalin, isolated from ...
8647264 - Ligation of cd40 rescues ramos-burkitt lymphoma b cells from calcium ionophore- and ant...
7992244 - Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
20594324 - Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-11-27
Journal Detail:
Title:  Oncogene     Volume:  26     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-26     Completed Date:  2007-05-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  2717-26     Citation Subset:  IM    
Affiliation:
Department of Physiopathology and Experimental Medicine, University of Siena, Siena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology*
Apoptosis / drug effects*,  physiology
Calcium / metabolism
Calpain / antagonists & inhibitors,  metabolism*
Caspase 3 / antagonists & inhibitors,  metabolism*
Caspase 7 / antagonists & inhibitors,  metabolism*
Cisplatin / pharmacology*
Endoplasmic Reticulum / drug effects,  metabolism
Enzyme Activation / drug effects
Humans
Melanoma / metabolism,  pathology*
Tumor Cells, Cultured
Tumor Suppressor Protein p53 / genetics,  metabolism*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Tumor Suppressor Protein p53; 15663-27-1/Cisplatin; 7440-70-2/Calcium; EC 3.4.22.-/Calpain; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspase 7

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively inv...
Next Document:  Serine protease Omi/HtrA2 targets WARTS kinase to control cell proliferation.